39 related articles for article (PubMed ID: 20356498)
1. [Effect of anti-cancer drugs on the expression of BIC/miR-155 in human pancreatic cancer PANC-1 cells].
Xia QS; Ishigaki Y; Sun L; Chen R; Motoo Y
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):123-7. PubMed ID: 20356498
[TBL] [Abstract][Full Text] [Related]
2. Human SMG-1 is involved in gemcitabine-induced primary microRNA-155/BIC up-regulation in human pancreatic cancer PANC-1 cells.
Xia QS; Ishigaki Y; Zhao X; Shimasaki T; Nakajima H; Nakagawa H; Takegami T; Chen ZH; Motoo Y
Pancreas; 2011 Jan; 40(1):55-60. PubMed ID: 20871480
[TBL] [Abstract][Full Text] [Related]
3. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma.
Kluiver J; van den Berg A; de Jong D; Blokzijl T; Harms G; Bouwman E; Jacobs S; Poppema S; Kroesen BJ
Oncogene; 2007 May; 26(26):3769-76. PubMed ID: 17173072
[TBL] [Abstract][Full Text] [Related]
4. 5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
Zhou J; Zhou Y; Yin B; Hao W; Zhao L; Ju W; Bai C
Oncol Rep; 2010 Jan; 23(1):121-8. PubMed ID: 19956872
[TBL] [Abstract][Full Text] [Related]
5. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
[TBL] [Abstract][Full Text] [Related]
6. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
8. Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells.
Fueger BJ; Hamilton G; Raderer M; Pangerl T; Traub T; Angelberger P; Baumgartner G; Dudczak R; Virgolini I
J Nucl Med; 2001 Dec; 42(12):1856-62. PubMed ID: 11752085
[TBL] [Abstract][Full Text] [Related]
9. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
Chen J; Ouyang ZG; Zhang SH; Zhen YS
Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
[TBL] [Abstract][Full Text] [Related]
11. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
Gao C; Zhang Z; Liu W; Xiao S; Gu W; Lu H
Cancer; 2010 Jan; 116(1):41-9. PubMed ID: 19890957
[TBL] [Abstract][Full Text] [Related]
12. Growth-inhibitory effect of phosphatidylinositol 3-kinase inhibitor on human pancreatic cancer cells and expression of Bcl-2 family.
Katayose K; Seki T; Ohba N; Funatomi H; Goto N; Mitamura K
Anticancer Res; 2003; 23(3B):2383-7. PubMed ID: 12894518
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of all-trans-retinoic acid on cultured human pancreatic cancer cells.
Guo J; Xiao B; Lou Y; Yan C; Zhan L; Wang D; Zhao W
J Gastroenterol Hepatol; 2006 Feb; 21(2):443-8. PubMed ID: 16509872
[TBL] [Abstract][Full Text] [Related]
14. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
Kluiver J; Haralambieva E; de Jong D; Blokzijl T; Jacobs S; Kroesen BJ; Poppema S; van den Berg A
Genes Chromosomes Cancer; 2006 Feb; 45(2):147-53. PubMed ID: 16235244
[TBL] [Abstract][Full Text] [Related]
15. miR-155: on the crosstalk between inflammation and cancer.
Tili E; Croce CM; Michaille JJ
Int Rev Immunol; 2009; 28(5):264-84. PubMed ID: 19811312
[TBL] [Abstract][Full Text] [Related]
16. microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression.
Liu Z; Du R; Long J; Guo K; Ge C; Bi S; Xu Y
Chin J Cancer Res; 2015 Jun; 27(3):267-78. PubMed ID: 26157323
[TBL] [Abstract][Full Text] [Related]
17. Regulation of B- and T-cell differentiation by a single microRNA.
Turner M; Vigorito E
Biochem Soc Trans; 2008 Jun; 36(Pt 3):531-3. PubMed ID: 18481999
[TBL] [Abstract][Full Text] [Related]
18. Retraction: Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF.
Cancer Res; 2018 Sep; 78(18):5466. PubMed ID: 30217876
[No Abstract] [Full Text] [Related]
19. Retraction to: miR-34 increases in vitro PANC-1 cell sensitivity to gemcitabine via targeting Slug/PUMA.
Cancer Biomark; 2022; 34(4):701. PubMed ID: 35912733
[No Abstract] [Full Text] [Related]
20. H 11 for Cancer.
Br Med J; 1943 Jul; 2(4306):78-9. PubMed ID: 20784938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
